Invention Grant
- Patent Title: Modulators of hemoglobin
-
Application No.: US16687474Application Date: 2019-11-18
-
Publication No.: US10683285B2Publication Date: 2020-06-16
- Inventor: Zhe Li
- Applicant: Global Blood Therapeutics, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Global Blood Therapeutics, Inc.
- Current Assignee: Global Blood Therapeutics, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Sheppard Mullin Richter & Hampton LLP
- Main IPC: C07D413/06
- IPC: C07D413/06 ; C07D417/06 ; A61K31/541 ; A61K31/5377
Abstract:
The present disclosure relates generally to compounds and pharmaceutical compositions suitable as modulators of hemoglobin, and methods for their use in treating disorders mediated by hemoglobin.
Public/Granted literature
- US20200157085A1 MODULATORS OF HEMOGLOBIN Public/Granted day:2020-05-21
Information query
